...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Current opinion in anaesthesiology >Fluid management in thoracic surgery
【24h】

Fluid management in thoracic surgery

机译：胸外科液体管理

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

PURPOSE OF REVIEW: This review presents the current available data to date regarding the perioperative risks associated with fluid management in thoracic surgery and its implications on the development of acute lung injury (ALI) as well as acute kidney injury (AKI). RECENT FINDINGS: The debate over the adequate fluid management during lung resection surgery has not been settled. Recent findings question the relationship between fluid administration and the development of ALI after lung resection surgery. New concepts including the capillary glycocalyx and the 'baby lung' model have reshaped thinking and therapy. Currently, there has been a growing interest in tissue hypoperfusion resulting from inadequate fluid resuscitation and the development of AKI after lung resection surgery. SUMMARY: Alternative fluid regimens to the traditional restrictive protocols used during thoracic surgery are being explored. These include normovolemic and goal-directed therapy protocols and the use of newer colloid solutions.
机译：审查的目的：这份审查提供了有关胸腔手术中液体管理相关的围手术期风险的最新可用数据，及其对急性肺损伤（ALI）和急性肾损伤（AKI）的发展的影响。最近的发现：关于肺切除手术中适当的液体管理的争论尚未解决。最近的发现质疑肺切除手术后输液与ALI的发展之间的关系。毛细血管糖萼和“婴儿肺”模型等新概念已经重塑了思维和治疗方法。当前，由于液体复苏不足和肺切除术后AKI的发展引起的对组织灌注不足的兴趣日益浓厚。摘要：正在探索替代胸外科手术中使用的传统限制性治疗方案的补液方案。这些措施包括正输血和针对目标的治疗方案，以及使用新型胶体溶液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号